admin

– Top-line data from this study remains on track to report in September 2017 – DEVON, Pa., June 08, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments, today announced that it has met its enrollment target of 16 patients in […]

DEVON, Pa., June 08, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments, today announced that it has met its enrollment target of 16 patients in its Phase 2 FAB-C (Treatment of Fragile X Syndrome Anxiety and Behavioral Challenges with CBD) […]

A rare scientific clinical trial involving cannabis-related compounds has produced stark evidence suggesting the medicinal benefits to be gained through controlled use of medical marijuana. Recently published results from a scientifically-conducted clinical trial show that treating young patients suffering from epilepsy with cannabidiol (“CBD”), a compound derived from marijuana, can significantly reduce and in some […]

Previously, support for medicinal marijuana has been based on anecdotal data. Now there could be science backing it. A new study published on Thursday (NZ time) has found medicine made from a marijuana extract can dramatically cut the number of seizures experienced by children with a severe form of epilepsy. It’s the first time a […]

LONDON, June 07, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH), (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that GW management will present at the Goldman Sachs 38th Annual Global Healthcare Conference on Wednesday, 14 June at 11:20 a.m. […]

A miracle boy born with the ultra-rare “two face” condition has defied all odds to survive to teenage years. Tres Johnson from Bernie, Missouri, celebrated his 13th birthday despite doctors giving him zero chance of survival at nearly every stage of his life. He has craniofacial duplication, a disorder caused by the SHH protein that […]

DEVON, Pa., June 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments, today announced that Zynerba’s Chief Financial Officer, Jim Fickenscher will present a company overview at the Jefferies 2017 Global Healthcare Conference on Thursday, June 8 at 1:30 p.m. […]

Zynerba Pharmaceuticals (NASDAQ:ZYNE) is a clinical stage biopharmaceutical company developing its proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The lead product candidates a are ZYN002 and ZYN001. ZYN002, is in Phase 2 clinical trial for adult patients with refractory epileptic focal seizures and osteoarthritis, as well as pediatric patients with fragile X syndrome; and […]

A major component of the legal cannabis industry is the CBD market. Matt Karnes of Greenwave Advisors is even more optimistic about the growth of the CBD market saying, “In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now, there are 15 states that allow CBD only – this […]

A boy born with a rare ‘two face’ condition has defied all odds to celebrate his 13th birthday. Tres Johnson from Bernie in Missouri, US, marked the milestone – despite doctors giving him ‘zero chance of survival’ when he was born. He has craniofacial duplication, whereby parts or all of the face are duplicated on […]

iStock A landmark clinical trial has shown that a compound in marijuana can ease life-threatening seizures in children with a rare and devastating form of epilepsy. Health24 previously reported that the Western Cape High Court has made a ruling allowing the possession, cultivation and usage of dagga in the home. ‘Gold standard’ evidence Cannabidiol (CBD) […]

A rare scientific clinical trial involving cannabis-related compounds has produced stark evidence suggesting the medicinal benefits to be gained through controlled use of medical marijuana. Recently published results from a scientifically-conducted clinical trial show that treating young patients suffering from epilepsy with cannabidiol (“CBD”), a compound derived from marijuana, can significantly reduce and in some […]